Citigroup gives a boost to Acorda Therapeutics (ACOR +4.5%) after the firm upgrades the shares...

|About: Acorda Therapeutics, Inc. (ACOR)|By:, SA News Editor

Citigroup gives a boost to Acorda Therapeutics (ACOR +4.5%) after the firm upgrades the shares to buy from hold, citing the recent pullback in price.